Teva Pharmaceuticals USA, Inc. (DE) | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Teva Pharmaceuticals USA, Inc. (DE)

Sort by

Viewing results 1‒25 of 680

Drug prices
Copycats take bite out of AbbVie’s best-selling Humira drug
...A Humira biosimilar from Teva Pharmaceuticals working with Alvotech earlier this year became the first drug that the US Food and Drug Administration granted interchangeable status, which lets pharmacists...
April 25, 2024
The Big Read
The world’s broken market for medicines
...“The FDA has not been inspecting facilities during Covid that much outside of the USA....
March 28, 2024
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Pfizer Inc
Pfizer to buy biotech group Biohaven for $11.6bn
...“Nurtec checked five of six key criteria for Pfizer in picking an asset to acquire, including: high complement to the portfolio, high level of clinical de-risking, high commercial potential, low infrastructure...
May 10, 2022
FT Magazine
Prediction markets can tell the future. Why is the US so afraid of them?
...In 1983, he founded Aristotle Inc, a technology consultancy that sold voter data to political campaigns....
November 10, 2023
Private equity
Is private equity actually worth it?
...The MSCI ACWI returned 8.48 per cent annualised in the 10 years to the end of 2023, while the MSCI USA index returned 11.98 per cent....
March 5, 2024
Legal services
Meet the FT top 20 in-house legal leaders
...Amid the turmoil, de Bie has kept an eye on the future....
October 12, 2022
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
Coronavirus treatment
Slow uptake of Pfizer’s Covid drug hints at end to sales boom
...Letter in response to this article: New body must help make antiviral drug available / From Michel Goldman, President, Institute for Interdisciplinary Innovation in Healthcare, Université libre de Bruxelles...
July 25, 2022
EU business regulation
EU court ruling expands Brussels’ powers to scrutinise tech mergers
...“This is a big deal,” said Salomé Cisnal de Ugarte, an antitrust partner at King & Spalding in Brussels....
July 13, 2022
FT Magazine
Inside the secret, often bizarre world that decides what porn you see
...“They have to be de facto regulators of what’s permissible content and what’s not,” he says....
June 24, 2022
InterviewNew York City
‘No big company is coming to the city’: biotech developer bemoans New York’s status
...But then when he left we had eight years literally of nothing,” Marcus said, faulting the administration of former mayor Bill de Blasio....
July 7, 2022
Berkshire Hathaway Inc
Buffett bought $1bn stake in Activision weeks before Microsoft deal
...It exited its position in generic drugs maker Teva and sold more than 70 per cent of its remaining shares in AbbVie and Bristol-Myers Squibb....
February 14, 2022
News in-depthArchegos Capital Management
Why did Wall Street loan billions to alleged fraudster Bill Hwang?
...Deutsche said in a statement it was “able to significantly de-risk our exposure to Archegos without incurring any losses”....
April 28, 2022
News in-depthNeil Shen
Neil Shen’s Sequoia China seeks ‘politically correct’ investment strategy
...He added only the “crème de la crème” of funds with strong local knowledge would survive....
July 20, 2022
LexNovartis AG
Novartis/Sandoz: selling generics would align Swiss giant with the times Premium content
...That might justify a steeper EV-to-forward ebitda multiple than the seven times commanded by quoted generics companies Teva and Viatris. The unit might fetch at least $15bn, according to Bernstein....
October 26, 2021
FT Alphaville
How to spend a million dollars, by Sam Bankman-Fried
...Michael Sklar, develops “nonstandard trial designs”, which seems to basically use maths to speed up the process of developing pharmaceutical studies....
December 19, 2022
FT Live
Innovation in Wealth Management Summit
Augmented intelligence for client-centric services
Thursday, 2 May9 Montague Close, London, UK
Moral Money
Sustainable investors target Pfizer’s pandemic profits Premium content
...It’s the sort of message that has become de rigueur since governance put the G in ESG....
December 3, 2021
US opioid epidemic
US states near $26bn opioid settlement with J&J, drug distributors
...Its case against Endo, Teva, and Allergan is currently being tried in state court. The settlement payments to New York will begin this summer and continue over the next 17 years....
July 20, 2021
Brooke Masters
Forget COP26 boasts — decarbonising takes thousands of tiny, boring steps
...brooke.masters@ft.com Follow Brooke Masters with myFT and on Twitter Letter in response to this article: Countries must meet their sustainability goals / From Otto de Bont, Chief Executive, Renewi, Milton...
September 22, 2021
US opioid epidemic
J&J to pay $230m to settle New York state opioid case
...James added that the pharmaceutical company’s heavy marketing of opioids was partially motivated by quotas for sales staff....
June 26, 2021
News in-depthSupply chains
Gloomy picture for paint highlights depth of supply chain crisis
...It is also used for applications in the marine, medical, military, pharmaceutical, semiconductor and textile industries....
November 8, 2021
Carlo de Notaristefani
Covid needs Big Pharma to set aside old rivalries
...The writer, a former Teva executive, is a lead adviser in manufacturing and supply chain to the US’s Operation Warp Speed For the pharmaceutical industry, working to combat Covid-19 has been palpably different...
February 10, 2021
Disease control and prevention
Malaria vaccine trial raises hopes of beating disease
...Halidou Tinto, regional director of the Institut de Recherche en Sciences de la Santé in the Burkina Faso department of Nanoro and the trial’s principal investigator, said he looked forward to demonstrating...
April 23, 2021
Genomics
Genomic sequencing head calls for ‘Bio Force’ to detect virus threats
...The UK has played a “fantastic leadership role”, recognising the value of sequencing the Sars-Cov-2 virus, De Souza said. It sequences about 10 per cent of all positive cases....
February 23, 2021
News in-depthCovid-19 vaccines
Should children be vaccinated to slow the spread of coronavirus?
...The pharmaceuticals groups insist child safety is paramount. Their studies all follow an “age de-escalation, dose escalation” method that gives small amounts to the older participants first....
May 7, 2021
Berkshire Hathaway Inc
Buffett pulls back on banks and bets on drugmakers
...The company already held stakes in the drugmakers Biogen, Johnson & Johnson and Teva Pharmaceuticals and DaVita, a kidney dialysis company. Mr Buffett did not respond to a request for comment....
November 17, 2020

Previous pagePage 1 of 28Next page